Substance abuse in India is a symptom of a larger mental health crisis Find out the root causes statistics and potential ...

John Mascarenhas, MD, discusses phase 1 data showing that INCA33989 is a well-tolerated therapy for calreticulin–mutant essential thrombocythemia, with early signs of efficacy and potential disease ...

An international study has shown that a drug called selumetinib can reduce the pain and size of tumors caused in adults by ...

Paradigm Biopharmaceuticals (ASX:PAR) is taking the acquisitive scenic route in its quest to develop an effective knee ...

Face yoga has gained online popularity in recent years for its promised antiaging, face slimming effects, but does it ...

Merck, a leading science and technology company, today announced the presentation of detailed results from Cohort B of the global Phase 2 WILLOW study (NCT05162586) evaluating enpatoran, an ...

Artificial intelligence is coming to medical and mental health care whether clinicians are ready or not. AI excels at ...

Selumetinib can reduce the pain and size of tumors caused in adults by neurofibromatosis type 1, a rare genetic disease for ...

Dr. Roberta Lotti honoured for a pioneering work on PC111, reinforcing Scinai's strategic option agreement to acquire the ...

Enpatoran, a TLR7/8 inhibitor, demonstrated clinically meaningful improvements in disease activity among patients with ...

New research by Sumeda Nandadasa, Ph.D., reveals how a key protein associated with Meckel-Gruber syndrome, nephronophthisis, ...